Today marks the first day of HIMSS 2019 in Orlando, Florida. Off to an energetic start, the MetaOptima Team had a busy start building and assembling our booth (#6884) in preparation for the big week that awaits of showcasing DermEngine and learning about the latest trends in all things health tech.
Health IT: an area of virtually endless growth (and frustrations) which has become a central hub for innovation. With HIMSS 2019 just around the corner, it’s time to take a look at some of the most anticipated sources for innovation from interoperability and big data to artificial intelligence (AI).
Natural Language Processing (NLP) is a $16 billion market opportunity positioned for great innovations in the healthcare sector. Designed to create comprehensive documentation solutions, this niche AI-based solution is already revolutionizing how data is utilized.
AI is the technology deemed to revolutionize human life to unprecedented levels. However, the degree to which it is widely accepted by users in healthcare is directly related to how much understanding there is on the basics of the functionality of the programming that powers intelligent algorithms.
Big data is an increasingly common term referring to the collection and analysis of large amounts of data to draw patterns of predictability for disease prevention and management. The potential of big data in dermatology can contribute to the early detection of skin cancer for higher survival rates.
The utilization of cloud-based dermatology EMRs has brought numerous advantages to daily practices as waiting time reduction, streamlined communication and patient active involvement. These improvements have optimized workflows for a better patient and doctor experience.
Skin cancer early detection constitutes the biggest challenge of dermatology practices. The application of teledermatology and total body photography has brought great improvements in detecting the disease at early stages with higher survival rates and important saving in the public health systems.